“Implementing and Optimising Good Manufacturing Practices”

Affordable and effective healthcare is a key concern amongst the populace in many countries and governments around the world have made reviewing (and reducing) healthcare costs a key priority. This development has indirectly resulted in pharmaceutical manufacturers looking for cost-effective manufacturing solutions to contain cost, with outsourced services and contract manufacturing as two of the key emerging trends.

Within Asia, countries that are benefiting from this trend include India, China, South Korea, Vietnam and Bangladesh. The region itself has became a key market for these multinational companies, with some industry reports indicating that South East Asia alone may account for a market value of USD69.1 billion in pharmaceutical retail prices in 2016. China alone may account for pharmaceutical sales of USD40 billion annually by 2013, and countries like Indonesia, Thailand and India have been projected to contribute to a sizable market value over the same period.

The ISPE Singapore Conference 2012 is the platform for the region’s pharmaceutical manufacturing professionals to gather, learn and share insights and views on issues and solutions relating to GMP. Through workshops, plenary keynotes and breakout sessions, International and regional speakers drawn from the regulatory, manufacturing and process development spheres will share their views and insights on key subject areas.

For details on the conference programme, please click here.